DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561,591 | -21.4% | 11,546 | +288.0% | 0.29% | -18.6% |
| Q2 2023 | $714,240 | -4.8% | 2,976 | 0.0% | 0.36% | -11.9% |
| Q1 2023 | $750,071 | -6.6% | 2,976 | -1.7% | 0.40% | -14.1% |
| Q4 2022 | $803,161 | +2.7% | 3,026 | 0.0% | 0.47% | -4.7% |
| Q3 2022 | $782,000 | -0.5% | 3,026 | -2.4% | 0.49% | +21.5% |
| Q2 2022 | $786,000 | -8.0% | 3,101 | -0.8% | 0.40% | +4.7% |
| Q1 2022 | $854,000 | -14.5% | 3,126 | +3.0% | 0.39% | -1.5% |
| Q4 2021 | $999,000 | +8.1% | 3,036 | 0.0% | 0.39% | -0.8% |
| Q3 2021 | $924,000 | +9.2% | 3,036 | -3.6% | 0.40% | +5.3% |
| Q2 2021 | $846,000 | +18.3% | 3,151 | -0.8% | 0.38% | +5.9% |
| Q1 2021 | $715,000 | +8.5% | 3,176 | +7.1% | 0.36% | -3.0% |
| Q4 2020 | $659,000 | +3.3% | 2,965 | 0.0% | 0.37% | -14.9% |
| Q3 2020 | $638,000 | +19.7% | 2,965 | -1.7% | 0.43% | -19.8% |
| Q2 2020 | $533,000 | +32.9% | 3,015 | +4.0% | 0.54% | +22.9% |
| Q1 2020 | $401,000 | -9.9% | 2,900 | 0.0% | 0.44% | +10.9% |
| Q4 2019 | $445,000 | +15.3% | 2,900 | +8.4% | 0.39% | +1.8% |
| Q3 2019 | $386,000 | +1.0% | 2,675 | 0.0% | 0.39% | -4.0% |
| Q2 2019 | $382,000 | +8.2% | 2,675 | 0.0% | 0.40% | +5.5% |
| Q1 2019 | $353,000 | +22.1% | 2,675 | -4.5% | 0.38% | +6.1% |
| Q4 2018 | $289,000 | – | 2,800 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |